QIAGEN powered by
  • English
  • Contact Sales
  • QIAGEN Webshop
  • Resellers
  • MyCLC
  • Qiagen_logo-1
  • Solutions
      • Discovery and Research
          • Biomarker and Target Discovery​
          • Single-Cell Genomics
          • Microbial/Metagenomics
          • Gene Regulation
          • Data and Pipeline Management
          • NGS Variant Assessment
          • SARS-CoV-2 Solutions
        • Discovery & Research – Powerful digital insights to help you innovate, integrate and translate scientific results into impactful discoveries.
      • Clinical NGS Testing
          • Oncology
              • Solid Tumors
              • Hematological Malignancies
              • Hereditary Cancers
          • Inherited Disorders
              • Rare & Undiagnosed Diseases
              • Carrier Screening
          • Cardiac Disorders
              • Arrhythmias
              • Cardiomyopathies
        • Clinical Testing Solutions – Deliver patient-specific reports for any NGS panel in minutes with on-demand, expert-curated content and professional interpretation service...
      • Pharmaceutical Development
          • Biomarker and Indication Selection
          • Cohort Stratification and CDx Design
          • Molecular Profiling
          • Trial Accrual and Drug Market Plans
          • Custom Drug Development Projects
        • Pharmaceutical Development – Whether searching for clinically applicable biomarkers, designing a new companion diagnostic (CDx), or honing your study accrual and go-to-m...
      • Partner Program
    • Know your biomarkers: PRKD1 linked to head and neck cancer? – A new cancer gene, PRKD1, has been identified as defining a subset of head and neck cancers. Learn more about its role in oncogenesis and ac...
    • QCI Interpret for Oncology – Clinical decision support software powered by augmented molecular intelligence that helps clinical labs not only make faster decisions—but...
    • QCI Interpret for Hereditary Diseases – Clinical decision support software powered by augmented molecular intelligence that gives clinical labs the best possible chance of solving ...
  • Products and Services
      • Products Overview
          • Discovery Insights Portfolio
              • Secondary Analysis
                  • QIAGEN CLC Workbench Premium
                  • QIAGEN CLC Genomics Workbench
                  • QIAGEN CLC Genome Finishing Module
                  • QIAGEN CLC Microbial Genomics Module
                  • QIAGEN CLC Main Workbench
                  • QIAGEN CLC Module and Plugin Overview
              • Interpretation and Visualization
                  • QIAGEN Ingenuity Pathway Analysis
                  • QIAGEN OmicSoft Suite
              • ‘Omics Databases
                  • QIAGEN Biomedical Knowledge Base
                  • QIAGEN DiseaseLand
                  • QIAGEN GeneticsLand
                  • QIAGEN OncoLand
                  • QIAGEN Single Сell Land
                  • ATCC Cell Line Land
                  • QIAGEN OmicSoft Land Explorer
              • Enterprise NGS Solutions
                  • QIAGEN CLC Genomics Server
                  • CLC Server Command Line Tools
                  • QIAGEN CLC Cloud Module
                  • QIAGEN OmicSoft Suite
              • NGS Variant Assessment
                  • QCI Interpret Translational
                  • ANNOVAR
              • QIAGEN Ingenuity Pathway Analysis
              • QIAGEN OmicSoft
              • QIAGEN CLC Genomics
          • Clinical Insights Portfolio
              • NGS Secondary Analysis
                  • QCI Secondary Analysis (Cloud-Based)
                  • QIAGEN CLC Genomics Workbench (Desktop)
              • Clinical Interpretation & Reporting
                  • QCI Interpret for Hereditary Diseases
                  • QCI Interpret for Oncology
                  • QCI Precision Insights
              • Gene Variant Databases
                  • COSMIC (Catalogue of Somatic Mutations in Cancer)
                  • HSMD (Human Somatic Mutation Database)
                  • HGMD (Human Gene Mutation Database)
                  • Clinical QKB (Clinical QIAGEN Knowledge Base)
          • Knowledge and Databases
              • QIAGEN Biomedical Knowledge Base
              • Gene Variant Databases
                  • COSMIC (Catalogue of Somatic Mutations in Cancer)
                  • HSMD (Human Somatic Mutation Database)
                  • HGMD (Human Gene Mutation Database)
                  • Clinical QKB (Clinical QIAGEN Knowledge Base)
              • Integrated ‘Omics Data
                  • QIAGEN DiseaseLand
                  • QIAGEN OncoLand
                  • QIAGEN Single Cell Land
                  • ATCC Cell Line Land
                  • QIAGEN Genetics Solution
          • Real-World Insights Portfolio
        • Human Gene Mutations Database (HGMD) – Solve more cases faster, with data you can trust using HGMD Professional, the gold standard for identifying inherited disease-causing mutati...
        • QIAGEN CLC Genomics Workbench – QIAGEN CLC Genomics Workbench is a powerful solution that works for everyone, no matter the workflow.
      • Services Overview
          • QIAGEN Discovery Bioinformatics Services
          • Clinical Analysis and Interpretation Services
          • Pharmaceutical Development Bioinformatic Services
        • Catalogue of Somatic Mutations in Cancer (COSMIC) – Explore the impact of somatic mutations in human cancer with the world’s largest and most comprehensive resource
    • QIAGEN IPA – Powerful tools to uncover the significance of data and identify new targets or candidate biomarkers within the context of biological systems
    • Human Somatic Mutation Database (HSMD) – A new somatic database developed by QIAGEN that contains extensive genomic content relevant to solid tumors and hematological malignancies.
    • QIAGEN OmicSoft – Powerful cloud-enabled ‘omics GUI, complete NGS analysis workflows and unparalleled curated content for immediate exploration
  • Resources
      • News
          • Blog
          • Press Releases
      • Science
          • Case Studies
          • Technical Information
          • Public Citations
          • Citation Guidelines
          • Allele Frequency Community
          • SARS-CoV-2 Resources
      • Webinars and Events
    • Lowering NGS analysis cost at lightspeed – Mar. 22 – Join this webinar to learn about how QIAGEN CLC LightSpeed can reduce the cost and time it takes to analyze WES and WGS data.
    • How to simplify somatic NGS analysis & reduce literature review time by 90% with HSMD – Mar. 23 – Discover a new database that can streamline your somatic NGS analysis and significantly reduce your literature review time—by up to 90%!
    • RNA-seq data analysis and interpretation using QIAGEN CLC and QIAGEN IPA – Apr. 6 – Learn how to easily analyze and interpret RNA-seq data using QIAGEN CLC Genomics Workbench software and QIAGEN Ingenuity Pathway Analysis.
  • Support
      • Technical Support
          • FAQs
          • Latest Improvements
          • QIAGEN CLC Tutorials
          • Product Manuals
          • Maintenance and Support
          • Contact Support
      • Training
          • IPA Training
          • Upcoming Webinars
          • Webinar Recordings
          • Technical Information
      • Downloads
          • Product Downloads
          • Module and Plugin Downloads
          • Example Data
          • 3d Graphics Support
      • System requirements
      • Licensing
          • License transfer
          • MyCLC
    • On-demand webinar: Investigation of Somatic and Germline Variants by COSMIC, HGMD and QIAGEN Databases – Identifying and studying actionable variants is of great interest to many investigators. In this webinar, COSMIC, HGMD and QIAGEN database w...
    • On-demand Webinar: Whole exome sequencing (WES) helps understand exceptional survival in rare sarcoma… – In this webinar, we present a unique case study of a treatment-naïve patient with aggressive metastatic uLMS with multiple pulmonary metast...
    • On-demand Webinar: CRISPR data analysis and interpretation using QIAGEN IPA and CLC Genomics Workbench – QIAGEN Digital Insights is hosting this 90-minute training focused on analyzing CRISPR high-throughput sequencing data using QIAGEN CLC Geno...
  • About
      • QIAGEN Digital Insights
          • About Us
          • Contact
          • Careers | QIAGEN Digital Insights
          • QIAGEN Corporate
  • Request a Trial
  • Product Login
  • Contact
  • Shop
      • How to Purchase
          • Contact Sales
          • QIAGEN Webshop
          • Resellers
          • MyCLC

Home > News | QIAGEN Digital Insights > Cancer, hereditary, and rare diseases data analysis

Translational
Webinar
Cancer, hereditary, and rare diseases data analysis

Author:

QIAGEN Digital Insights

Thursday, April 16, 2015

Cancer, hereditary, and rare diseases data analysis

Webinar

Want to learn how to find the whole truth in your cancer and hereditary diseases NGS data?

Anika Joecker, PhD, Product Marketing Manager, introduces our new Biomedical Genomics Workbench and shows how you get accurate and trustworthy results from whole genome, exome, targeted amplicon, transcriptome as well as epigenetic NGS data in just one step.

 

Share on:

Facebook | Twitter | LinkedIn


Tags

Categories
  • Clinical
  • Discovery
  • Events
  • Promotions
  • Translational
  • Webinar

Related Posts

  • February 9, 2015NGS solution: Analysis and interpretation
  • February 9, 2015Ingenuity Variant Analysis Winter Release
  • March 4, 2015Rare disease specialists uncover novel pediatric syndrome
  • April 15, 2015NGS variant discovery
  • April 13, 2015Molecular mechanisms of ocular diseases investigated by use of RNA-Seq
Upcoming Webinars
December 29, 2023
オンサイトハンズオンセミナーご希望調査
May 12, 2023 - May 12, 2023
【5/12開催】2023年 QDI QIAGEN IPA ユーザーグループミーティング
April 20, 2023 - April 28, 2023
【4/20&4/28開催】QIAGEN Digital Insights のポートフォリオ – キアゲンバイオインフォマティクス製品ラインナップのご紹介
April 06, 2023 - April 12, 2023
【4/6&4/12開催】リン酸化プロテオミクスデータの解釈 ~QIAGEN Ingenuity Pathway Analysis を用いて~

Follow Us

Contact Us

Sample to Insight
  • © QIAGEN 2013–. All rights reserved
  • Privacy Policy
  • Sitemap
  • Trademarks & Disclaimers
  • Terms & Conditions